Global Meningitis B Vaccine Market Research Report 2025(Status and Outlook)

March 2025 | 217 pages | ID: G19CC8A62287EN
Bosson Research

Abstracts

Report Overview

Japanese meningitis vaccine is a vaccine used to prevent Japanese encephalitis, and vaccination against Japanese encephalitis is an effective measure to prevent Japanese encephalitis.

This report provides a deep insight into the global Meningitis B Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningitis B Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningitis B Vaccine market in any manner.

Global Meningitis B Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GlaxoSmithKline

Novartis

BEXSERO

TRUMENBA

Pfizer

Sanofi Pasteur Inc

Wyeth Pharmaceuticals

Inc.

Market Segmentation (by Type)

MenACWY (Conjugate) Vaccine

MenB (Recombinant Protein) Vaccine

Market Segmentation (by Application)

Hospital

Clinic

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Meningitis B Vaccine Market
• Overview of the regional outlook of the Meningitis B Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningitis B Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Meningitis B Vaccine
1.2 Key Market Segments
  1.2.1 Meningitis B Vaccine Segment by Type
  1.2.2 Meningitis B Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL MENINGITIS B VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Meningitis B Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Meningitis B Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL MENINGITIS B VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Meningitis B Vaccine Product Life Cycle
3.3 Global Meningitis B Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Meningitis B Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Meningitis B Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Meningitis B Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Meningitis B Vaccine Market Competitive Situation and Trends
  3.8.1 Meningitis B Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Meningitis B Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MENINGITIS B VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Meningitis B Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MENINGITIS B VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Meningitis B Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Meningitis B Vaccine Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL MENINGITIS B VACCINE MARKET BY REGION

6.1 Global Meningitis B Vaccine Market Size by Region
  6.1.1 Global Meningitis B Vaccine Market Size by Region
  6.1.2 Global Meningitis B Vaccine Market Size Market Share by Region
6.2 Global Meningitis B Vaccine Sales by Region
  6.2.1 Global Meningitis B Vaccine Sales by Region
  6.2.2 Global Meningitis B Vaccine Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Meningitis B Vaccine Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Meningitis B Vaccine Market Size by Type
7.3 North America Meningitis B Vaccine Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Meningitis B Vaccine Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Meningitis B Vaccine Market Size by Type
8.3 Europe Meningitis B Vaccine Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Meningitis B Vaccine Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Meningitis B Vaccine Market Size by Type
9.3 Asia-Pacific Meningitis B Vaccine Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Meningitis B Vaccine Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Meningitis B Vaccine Market Size by Type
10.3 South America Meningitis B Vaccine Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Meningitis B Vaccine Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Meningitis B Vaccine Market Size by Type
11.3 Middle East and Africa Meningitis B Vaccine Market Size by Application

12 MENINGITIS B VACCINE MARKET PRODUCTION BY REGION

12.1 Global Production of Meningitis B Vaccine by Region(2020-2025)
12.2 Global Meningitis B Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Meningitis B Vaccine Production
  12.4.1 North America Meningitis B Vaccine Production Growth Rate (2020-2025)
  12.4.2 North America Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Meningitis B Vaccine Production
  12.5.1 Europe Meningitis B Vaccine Production Growth Rate (2020-2025)
  12.5.2 Europe Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Meningitis B Vaccine Production (2020-2025)
  12.6.1 Japan Meningitis B Vaccine Production Growth Rate (2020-2025)
  12.6.2 Japan Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Meningitis B Vaccine Production (2020-2025)
  12.7.1 China Meningitis B Vaccine Production Growth Rate (2020-2025)
  12.7.2 China Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

13 MENINGITIS B VACCINE MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Meningitis B Vaccine Sales Market Share by Type (2020-2033)
13.3 Global Meningitis B Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global Meningitis B Vaccine Price by Type (2020-2033)

14 MENINGITIS B VACCINE MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Meningitis B Vaccine Market Sales by Application (2020-2033)
14.3 Global Meningitis B Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global Meningitis B Vaccine Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 GlaxoSmithKline
  15.1.1 GlaxoSmithKline Basic Information
  15.1.2 GlaxoSmithKline Meningitis B Vaccine Product Overview
  15.1.3 GlaxoSmithKline Meningitis B Vaccine Product Market Performance
  15.1.4 GlaxoSmithKline Business Overview
  15.1.5 GlaxoSmithKline SWOT Analysis
  15.1.6 GlaxoSmithKline Recent Developments
15.2 Novartis
  15.2.1 Novartis Basic Information
  15.2.2 Novartis Meningitis B Vaccine Product Overview
  15.2.3 Novartis Meningitis B Vaccine Product Market Performance
  15.2.4 Novartis Business Overview
  15.2.5 Novartis SWOT Analysis
  15.2.6 Novartis Recent Developments
15.3 BEXSERO
  15.3.1 BEXSERO Basic Information
  15.3.2 BEXSERO Meningitis B Vaccine Product Overview
  15.3.3 BEXSERO Meningitis B Vaccine Product Market Performance
  15.3.4 BEXSERO Business Overview
  15.3.5 BEXSERO SWOT Analysis
  15.3.6 BEXSERO Recent Developments
15.4 TRUMENBA
  15.4.1 TRUMENBA Basic Information
  15.4.2 TRUMENBA Meningitis B Vaccine Product Overview
  15.4.3 TRUMENBA Meningitis B Vaccine Product Market Performance
  15.4.4 TRUMENBA Business Overview
  15.4.5 TRUMENBA Recent Developments
15.5 Pfizer
  15.5.1 Pfizer Basic Information
  15.5.2 Pfizer Meningitis B Vaccine Product Overview
  15.5.3 Pfizer Meningitis B Vaccine Product Market Performance
  15.5.4 Pfizer Business Overview
  15.5.5 Pfizer Recent Developments
15.6 Sanofi Pasteur Inc
  15.6.1 Sanofi Pasteur Inc Basic Information
  15.6.2 Sanofi Pasteur Inc Meningitis B Vaccine Product Overview
  15.6.3 Sanofi Pasteur Inc Meningitis B Vaccine Product Market Performance
  15.6.4 Sanofi Pasteur Inc Business Overview
  15.6.5 Sanofi Pasteur Inc Recent Developments
15.7 Wyeth Pharmaceuticals
  15.7.1 Wyeth Pharmaceuticals Basic Information
  15.7.2 Wyeth Pharmaceuticals Meningitis B Vaccine Product Overview
  15.7.3 Wyeth Pharmaceuticals Meningitis B Vaccine Product Market Performance
  15.7.4 Wyeth Pharmaceuticals Business Overview
  15.7.5 Wyeth Pharmaceuticals Recent Developments
15.8 Inc.
  15.8.1 Inc. Basic Information
  15.8.2 Inc. Meningitis B Vaccine Product Overview
  15.8.3 Inc. Meningitis B Vaccine Product Market Performance
  15.8.4 Inc. Business Overview
  15.8.5 Inc. Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Meningitis B Vaccine Market Size by Type (M USD)
Table 4. Global Meningitis B Vaccine Market Size by Application (M USD)
Table 5. Meningitis B Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Meningitis B Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Meningitis B Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Meningitis B Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Meningitis B Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningitis B Vaccine as of 2024)
Table 11. Global Market Meningitis B Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Meningitis B Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers Meningitis B Vaccine Product Type
Table 14. Global Meningitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningitis B Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Meningitis B Vaccine Market Size Comparison by Region (M USD)
Table 26. Global Meningitis B Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Meningitis B Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global Meningitis B Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global Meningitis B Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America Meningitis B Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Meningitis B Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America Meningitis B Vaccine Sales by Type (K MT)
Table 33. North America Meningitis B Vaccine Market Size by Type (M USD)
Table 34. North America Meningitis B Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America Meningitis B Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America Meningitis B Vaccine Sales by Application (K MT)
Table 37. North America Meningitis B Vaccine Market Size by Application (M USD)
Table 38. North America Meningitis B Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America Meningitis B Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Meningitis B Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Meningitis B Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe Meningitis B Vaccine Sales by Type (K MT)
Table 43. Europe Meningitis B Vaccine Market Size by Type (M USD)
Table 44. Europe Meningitis B Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe Meningitis B Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Meningitis B Vaccine Sales by Application (K MT)
Table 47. Europe Meningitis B Vaccine Market Size by Application (M USD)
Table 48. Europe Meningitis B Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe Meningitis B Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Meningitis B Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Meningitis B Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Meningitis B Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific Meningitis B Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific Meningitis B Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Meningitis B Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Meningitis B Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific Meningitis B Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific Meningitis B Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Meningitis B Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America Meningitis B Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Meningitis B Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America Meningitis B Vaccine Sales by Type (K MT)
Table 63. South America Meningitis B Vaccine Market Size by Type (M USD)
Table 64. South America Meningitis B Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America Meningitis B Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America Meningitis B Vaccine Sales by Application (K MT)
Table 67. South America Meningitis B Vaccine Market Size by Application (M USD)
Table 68. South America Meningitis B Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America Meningitis B Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Meningitis B Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Meningitis B Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Meningitis B Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa Meningitis B Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa Meningitis B Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Meningitis B Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Meningitis B Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa Meningitis B Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa Meningitis B Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Meningitis B Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global Meningitis B Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global Meningitis B Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Meningitis B Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Meningitis B Vaccine Sales by Type (K MT)
Table 89. Global Meningitis B Vaccine Market Size by Type (M USD)
Table 90. Global Meningitis B Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global Meningitis B Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global Meningitis B Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global Meningitis B Vaccine Market Size Share by Type (2020-2033)
Table 94. Global Meningitis B Vaccine Sales (K MT) by Application
Table 95. Global Meningitis B Vaccine Market Size by Application(M USD)
Table 96. Global Meningitis B Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global Meningitis B Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global Meningitis B Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Meningitis B Vaccine Market Share by Application (2020-2033)
Table 100. Global Meningitis B Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. GlaxoSmithKline Basic Information
Table 102. GlaxoSmithKline Meningitis B Vaccine Product Overview
Table 103. GlaxoSmithKline Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline SWOT Analysis
Table 106. GlaxoSmithKline Recent Developments
Table 107. Novartis Basic Information
Table 108. Novartis Meningitis B Vaccine Product Overview
Table 109. Novartis Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Novartis Business Overview
Table 111. Novartis SWOT Analysis
Table 112. Novartis Recent Developments
Table 113. BEXSERO Basic Information
Table 114. BEXSERO Meningitis B Vaccine Product Overview
Table 115. BEXSERO Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. BEXSERO Business Overview
Table 117. BEXSERO SWOT Analysis
Table 118. BEXSERO Recent Developments
Table 119. TRUMENBA Basic Information
Table 120. TRUMENBA Meningitis B Vaccine Product Overview
Table 121. TRUMENBA Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. TRUMENBA Business Overview
Table 123. TRUMENBA Recent Developments
Table 124. Pfizer Basic Information
Table 125. Pfizer Meningitis B Vaccine Product Overview
Table 126. Pfizer Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Pfizer Business Overview
Table 128. Pfizer Recent Developments
Table 129. Sanofi Pasteur Inc Basic Information
Table 130. Sanofi Pasteur Inc Meningitis B Vaccine Product Overview
Table 131. Sanofi Pasteur Inc Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Sanofi Pasteur Inc Business Overview
Table 133. Sanofi Pasteur Inc Recent Developments
Table 134. Wyeth Pharmaceuticals Basic Information
Table 135. Wyeth Pharmaceuticals Meningitis B Vaccine Product Overview
Table 136. Wyeth Pharmaceuticals Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Wyeth Pharmaceuticals Business Overview
Table 138. Wyeth Pharmaceuticals Recent Developments
Table 139. Inc. Basic Information
Table 140. Inc. Meningitis B Vaccine Product Overview
Table 141. Inc. Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Inc. Business Overview
Table 143. Inc. Recent Developments
List of Figures
Figure 1. Product Picture of Meningitis B Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningitis B Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Meningitis B Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Meningitis B Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningitis B Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Meningitis B Vaccine Product Life Cycle
Figure 13. Meningitis B Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Meningitis B Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Meningitis B Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Meningitis B Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Meningitis B Vaccine
Figure 19. Global Meningitis B Vaccine Market PEST Analysis
Figure 20. Global Meningitis B Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Meningitis B Vaccine Market Size by Region
Figure 27. Global Meningitis B Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global Meningitis B Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Meningitis B Vaccine Market Size (M USD) by Country
Figure 33. USA Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Meningitis B Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Meningitis B Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Meningitis B Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Meningitis B Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Meningitis B Vaccine Market Size (M USD)by Type
Figure 40. North America Meningitis B Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Meningitis B Vaccine Market Size (M USD) by Country
Figure 45. Germany Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Meningitis B Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Meningitis B Vaccine Market Size (M USD) by Type
Figure 56. Europe Meningitis B Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Meningitis B Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Meningitis B Vaccine Market Size (M USD) by Country
Figure 61. China Meningitis B Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Meningitis B Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Meningitis B Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Meningitis B Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Meningitis B Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Meningitis B Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Meningitis B Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Meningitis B Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Meningitis B Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Meningitis B Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Meningitis B Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific Meningitis B Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Meningitis B Vaccine Market Size (M USD) by Country
Figure 77. Brazil Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Meningitis B Vaccine Market Size (M USD) by Type
Figure 84. South America Meningitis B Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Meningitis B Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Meningitis B Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Meningitis B Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Meningitis B Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa Meningitis B Vaccine Market Size (M USD) by Application
Figure 101. Global Meningitis B Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America Meningitis B Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Meningitis B Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Meningitis B Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China Meningitis B Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Meningitis B Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of Meningitis B Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of Meningitis B Vaccine by Type in 2024
Figure 110. Market Size Share of Meningitis B Vaccine by Type (2020-2033)
Figure 111. Market Size Share of Meningitis B Vaccine by Type in 2024
Figure 112. Global Meningitis B Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Meningitis B Vaccine Market Size by Application(M USD)
Figure 115. Global Meningitis B Vaccine Market Share by Application
Figure 116. Global Meningitis B Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global Meningitis B Vaccine Sales Market Share by Application in 2024
Figure 118. Global Meningitis B Vaccine Market Share by Application (2020-2033)
Figure 119. Global Meningitis B Vaccine Market Share by Application in 2024
Figure 120. Global Meningitis B Vaccine Sales Growth Rate by Application (2020-2033)